Urinary miRNA in Endometrial Cancer Study

Royal Cornwall Hospitals Trust164 enrolled

Overview

This study is a prospective feasibility study with the addition of a retrospective cohort study on the the expression of microRNA in urine in endometrial cancer patients.

Study Type

OBSERVATIONAL

Enrollment

164

Conditions

Endometrial Cancer

Interventions

Urinary miRNADIAGNOSTIC_TEST

MiRNA detection in urine

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Confirmed diagnosis of endometrial cancer * Age: 18 years or older Exclusion Criteria: * Prior or coexisting other malignancies * Autoimmune disorders (other than diabetes mellitus)

Locations (1)

Royal Cornwall Hospital

Truro, Cornwal, United Kingdom

Outcomes

Primary Outcomes

Accuracy of predictive value of miRNA test in detecting endometrial cancer

To determine if miRNA can distinguish endometrial cancer patients from healthy patients

Time frame: 6 months

Secondary Outcomes

Correlation to final histology

To determine how well miRNA correlates with final histology, i.e. can miRNA determine the subtype of endometrial cancer

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.